Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo

Molecular Medicine Reports

Volumn 4, Issue 4, 2011, Pages 667-674

  Jiang, Chun ^a   Tan, Tan ^b   Yi, Xiao Ping ^a   Shen, Hong ^a   Li, Yi Xiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The First People's Hospital of Chenzhou Department of Critical Care Medicine   (China)

Author keywords

Apoptosis; Pancreatic cancer; Proliferation; Survivin; XIAP

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 7; SHORT HAIRPIN RNA; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; BIOLOGICAL TRAIT; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; COMPARATIVE STUDY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; SW1990 CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; GENE THERAPY; GENETIC VECTORS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LENTIVIRUS; MICE; PANCREATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

LENTIVIRUS;

EID: 79957643398     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.472     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ and Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001. (Pubitemid 32467043)
3. Wang SL, Hawkins CJ, Yoo SJ, Muller HAJ and Hay BA: The Drosophila caspase inhibitor DIAP1 is essential for cell survival and is negatively regulated by HID. Cell 98: 453-463, 1999. (Pubitemid 29402483)
4. Zangemeister-Wittke U and Simon HU: An IAP in action - the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle 3: 1121-1123, 2004. (Pubitemid 40268627)
5. Kumamoto H and Ooya K: Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas. Virchows Archiv 444: 164-170, 2004. (Pubitemid 38315295)
6. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S and Korneluk RG: IAP-targeted therapies for cancer. Oncogene 27: 6252-6275, 2008.
7. Chen P, Li J, Ge LP, Dai CH and Li XQ: Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Respirology 15: 501-509, 2010.
8. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T and Altieri DC: IAP regulation of metastasis. Cancer Cell 17: 53-64, 2010.
9. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ and Borden EC: Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 11: 915-923, 2004.
10. Kyriazis AP, McCombs WB III, Sandberg AA, Kyriazis AA, Sloane NH and Lepera R: Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res 43: 4393-4401, 1983. (Pubitemid 13041878)
11. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
12. Bilim V, Yuuki K, Itoi T, Muto A, Kato T, Nagaoka A, Motoyama T and Tomita Y: Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. Br J Cancer 98: 941-949, 2008. (Pubitemid 351341617)
13. Kunze D, Wuttig D, Fuessel S, Kraemer K, Kotzsch M, Meye A, Grimm MO, Hakenberg OW and Wirth MP: Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X-L) in bladder cancer cells. Anticancer Res 28: 2259-2263, 2008.
14. Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM and Fulda S: Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Cancer Res 68: 7956-7965, 2008.
15. Liston P, Fong WG and Korneluk RG: The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568-8580, 2003. (Pubitemid 38019194)
16. Evans JD, Cornford PA, Dodson A, Greenhalf W, Foster CS and Neoptolemos JP: Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 1: 254-262, 2001. (Pubitemid 33674930)
17. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H and Ungefroren H: Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene 19: 5477-5486, 2000. (Pubitemid 32000915)
18. Srinivasula SM and Ashwell JD: IAPs: what's in a name? Mol Cell 30: 123-135, 2008.
19. Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, Salvesen GS, Reed JC and Altieri DC: An IAP-IAP complex inhibits apoptosis. J Biol Chem 279: 34087-34090, 2004. (Pubitemid 39318028)
20. Krepela E, Dankova P, Moravcikova E, Krepelova A, Prochazka J, Cermak J, Schutzner J, Zatloukal P and Benkova K: Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol 35: 1449-1462, 2009.
21. Sensintaffar J, Scott FL, Peach R and Hager JH: XIAP is not required for human tumor cell survival in the absence of an exogenous death signal. BMC Cancer 10: 11, 2010.
22. Zhu Y, Roshal M, Li F, Blackett J, Planelles V: Upregulation of survivin by HIV-1 Vpr. Apoptosis 8: 71-79, 2003. (Pubitemid 36133140)
23. Levkau B, Garton KJ, Ferri N, Kloke K, Nofer JR, Baba HA, Raines EW and Breithardt G: xIAP induces cell-cycle arrest and activates nuclear factor-kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res 88: 282-290, 2001. (Pubitemid 32173751)
24. Altieri DC: survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70, 2008.
25. Hamacher R, Schmid RM, Saur D and Schneider G: Apoptotic pathways in pancreatic ductal adenocarcinoma. Mol Cancer 7: 64, 2008.
26. Lu M, Lin SC, Huang YH, Kang YJ, Rich R, Lo YC, Myszka D, Han JH and Wu H: XIAP induces NF-kappa B activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 26: 689-702, 2007. (Pubitemid 46856243)
27. Fornaro M, Plescia J, Chheang S, Tallini G, Zhu YM, King M, Altieri DC and Languino LR: Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem 278: 50402-50411, 2003. (Pubitemid 37548884)
28. Caldas H, Jiang YY, Holloway MP, Fangusaro J, Mahotka C, Conway EM and Altura RA: survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24: 1994-2007, 2005.